Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Discover Oncology|October 1, 2022
Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2ANichelle C Whitlock, Margaret E White, Brian J Capaldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2025
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3-Targeted Single-Domain Antibody PETStanley Fayn, Woonghee Lee, Falguni Basuli, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2026
A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver CancerDivya M Nambiar, Thomas J Esparza, Woonghee Lee, et al.
Molecular Imaging|May 3, 2019
Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, AvelumabElaine M Jagoda, Olga Vasalatiy, Falguni Basuli, et al.
Scientific Reports|January 14, 2018
Development of a PET radioligand for potassium channels to image CNS demyelinationPedro Brugarolas, Jorge E Sánchez-Rodríguez, Hsiu-Ming Tsai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2026
Development of novel GPC2-directed radiotheranostics and CAR T-cell therapy for neuroblastomaIra Phadke, Divya Nambiar, George Diehl, et al.
Cell Reports|November 29, 2023
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capabilityYang Feng, Jaewon Lee, Liping Yang, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Distributable, Metabolic PET Reporting of TuberculosisR M Naseer Khan, Yong-Mo Ahn, Gwendolyn A Marriner, et al.
Pageof 9